GREY:NEPTF - Post by User
Post by
seanj1on Jul 16, 2021 9:59am
214 Views
Post# 33558760
Transition
Transition Well not a pretty picture as far as sp is concerned. But I agree that B2C model was not going to get the company anywhere since most major companies have developed their own in house extraction facilities. If not sure just look at Medipharm stock. I like the transition model, Sprout was a great buy and that alone will give a nice boost to revenues going forward. As I said before Cannabis business in Canada will not be that profitable at least not for a while. The CBD in household products will be a major boost and I think that is coming. Nutraceutical and medical branches can be game changers . I am happy to hear that Transition phase has been completed and company does not plan to issue any more shares. Cash balance is in a good position as well. I also don't think that institutional investors are stupid to stay with the company at almost a record share count if they didn't expect good things to come.